Minnie Baylor-Henry,
JD
President, B-Henry & Associates
Minnie Baylor-Henry recently served as Worldwide Vice President for Regulatory Affairs, Johnson & Johnson. She has served as Consultant in the Life Sciences Regulatory Practice at Deloitte & Touche LLP based on her extensive expertise as Johnson & Johnson Vice President for Global Regulatory Affairs, Over the Counter products; and as Senior Director, Regulatory Affairs. Before joining Johnson & Johnson, Minnie served as the US Food and Drug Administration Director of the Division of Drug Marketing, Advertising, and Communications, and as the US Food and Drug Administration’s National Health Fraud Coordinator. A pharmacist and an attorney, Minnie received her pharmacy degree from Howard University and her JD from Catholic University. She has been a longtime member of DIA and has served as President of the DIA Board.
Fellows of DIA
-
PhD •Chair, Fellows of DIA
President, Japan Self-Medication Industry -
-
JD • President, B-Henry & Associates -
MD, PhD • Pharmacovigilance Expert -
MD • Professor of Clinical Pharmacology, St. Vincent's Hospital -
MBA • President, International Regulatory Affairs Group LLC -
MPH, PhD • Global Chief, Sci Affairs; Sr VP, Head, Center for Advanced Evidence Generation
IQVIA -
PhD • Senior Advisor, Strategic Programs,Center for Drug Evaluation and Research, US Food and Drug Administration -
MD • Senior VP, Chief Medical Officer, Director, Corporate Medical Affairs HQ, Eisai Co., Ltd. -
MBA • Chairman, CISCRP; Director of Sponsored Research, Tufts Center For the Study of Drug Development -
PhD • Corporate Vice President
PAREXEL International -
MD • Senior Vice-President, Industrie Sante -
MD • Deputy Director, FDA Liaison to the EMA, Office of International Programs, OC -
MD • Deputy Director, Integrated Delivery, and Lead for Global Regulatory Systems Initiatives
Bill and Melinda Gates Foundation -
MD, JD • Senior Vice President, Head of Global Regulatory Affairs and Clinical Safety, Merck & Co., Inc. -
MS • Representative, NM Consulting -
PhD • Advisor, Digital Channels and eCapabilities, Eli Lilly and Company -
MD • Chief Medical Officer & EVP, Horizon Pharma, Inc. -
DVM, MBA • Director Biopeople, University of Copenhagen -
PhD • Professor and Director, Institute of Drug Regulatory Science, Shenyang Pharmaceutical University, Venture Partner, Lilly Asia Ventures